Literature DB >> 1176966

Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide.

C J Bradish, K Allner, R Fitzgeorge.   

Abstract

Mice were infected i.c. or i.p. by an avirulent clone of Semliki Forest virus at various times before or after the i.p. administration of a single dose of cyclophosphamide. Consequent changes in the patterns of viraemia and antibody production are interpreted in terms of the potentiation of the initial infection or the decreased resistance to subsequent lethal challenge. These change demonstrate two distinct modes of immunomodification determined by the time of cyclophosphamide administration in relation to virus infection, but not correlated with the death or protection of individual mice. These results are discussed in relation to the early regulatory functions of T and B cells which may influence the expression of virulence but escape conventional assay during the critical first 3 days following infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176966     DOI: 10.1099/0022-1317-28-2-225

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.

Authors:  N Stebbing; I J Lindley
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.

Authors:  W A Boere; B J Benaissa-Trouw; T Harmsen; T Erich; C A Kraaijeveld; H Snippe
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

4.  PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.

Authors:  Gerald Barry; Lucy Breakwell; Rennos Fragkoudis; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Alain Kohl; John K Fazakerley
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.